Gérard Michel London
#108,696
Most Influential Person Now
Gérard Michel London's AcademicInfluence.com Rankings
Gérard Michel Londonphilosophy Degrees
Philosophy
#4499
World Rank
#7035
Historical Rank
Logic
#1933
World Rank
#2806
Historical Rank

Download Badge
Philosophy
Why Is Gérard Michel London Influential?
(Suggest an Edit or Addition)Gérard Michel London's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Impact of aortic stiffness on survival in end-stage renal disease. (1999) (2181)
- Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. (2003) (1745)
- Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’ (2010) (1588)
- Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. (1999) (1549)
- Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease (2001) (1181)
- Impact of Aortic Stiffness Attenuation on Survival of Patients in End-Stage Renal Failure (2001) (1021)
- Arterial stiffening and vascular calcifications in end-stage renal disease. (2000) (984)
- Arterial Wave Reflections and Survival in End-Stage Renal Failure (2001) (889)
- Central Pulse Pressure and Mortality in End-Stage Renal Disease (2002) (831)
- Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. (2012) (795)
- Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. (1998) (607)
- Arterial calcifications and bone histomorphometry in end-stage renal disease. (2004) (569)
- Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. (2005) (541)
- Aortic pulse wave velocity index and mortality in end-stage renal disease. (2003) (528)
- Cardiac and arterial interactions in end-stage renal disease. (1996) (497)
- Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive Patient: A Comparison With Atenolol (2001) (467)
- Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. (2001) (466)
- Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. (2007) (434)
- Stiffness of Capacitive and Conduit Arteries: Prognostic Significance for End-Stage Renal Disease Patients (2005) (399)
- Aortic and large artery compliance in end-stage renal failure. (1990) (398)
- Iron Therapy, Advanced Oxidation Protein Products, and Carotid Artery Intima-Media Thickness in End-Stage Renal Disease (2002) (385)
- Atherosclerosis and arteriosclerosis in chronic renal failure. (1997) (356)
- Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. (2013) (348)
- Cardiac Hypertrophy, Aortic Compliance, Peripheral Resistance, and Wave Reflection in End‐Stage Renal Disease: Comparative Effects of ACE Inhibition and Calcium Channel Blockade (1994) (330)
- Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. (2004) (329)
- Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (2014) (328)
- Vascular calcification in chronic kidney disease. (2004) (323)
- Arterial stiffness and pulse pressure in CKD and ESRD. (2012) (321)
- Arterial stiffness and kidney function. (2004) (317)
- Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. (2006) (312)
- Pathophysiology of anaemia: focus on the heart and blood vessels. (2000) (304)
- Comparative effects of aging in men and women on the properties of the arterial tree. (2001) (300)
- Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. (2008) (272)
- Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia (2005) (261)
- Increased systolic pressure in chronic uremia. Role of arterial wave reflections. (1992) (259)
- Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects (1997) (258)
- Influence of sex on arterial hemodynamics and blood pressure. Role of body height. (1995) (250)
- Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. (2001) (243)
- Therapeutic studies and arterial stiffness in hypertension: recommendations of the European Society of Hypertension (2000) (242)
- Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. (1993) (240)
- Uremic cardiomyopathy: an inadequate left ventricular hypertrophy. (1987) (239)
- Influence of body height on pulsatile arterial hemodynamic data. (1998) (235)
- Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. (2003) (235)
- Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. (1988) (233)
- Influence of arterial pulse and reflected waves on blood pressure and cardiac function. (1999) (232)
- Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: a noninvasive study. (1989) (227)
- Arterial structure and function in end-stage renal disease. (2002) (224)
- The systemic nature of CKD (2017) (218)
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. (2015) (212)
- Left ventricular alterations and end-stage renal disease. (2002) (210)
- Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects (2004) (204)
- Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. (1998) (201)
- Cardiac disease in chronic uremia: pathogenesis. (1997) (200)
- Remodeling of the radial artery in response to a chronic increase in shear stress. (1996) (199)
- Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. (2001) (194)
- Clinical Utility of Aortic Pulses and Pressures Calculated From Applanated Radial-Artery Pulses (2003) (193)
- Arterial functions: how to interpret the complex physiology. (2010) (190)
- Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. (2005) (183)
- Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors. (1993) (182)
- Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. (2010) (178)
- An evaluation of large arteries compliance in man. (1979) (168)
- Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. (1989) (164)
- Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. (2007) (161)
- Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial. (2015) (161)
- Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. (1997) (161)
- In Vivo Shear Stress Determines Circulating Levels of Endothelial Microparticles in End-Stage Renal Disease (2007) (159)
- Carotid stiffness is associated with incident stroke: a systematic review and individual participant data meta-analysis. (2015) (155)
- Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. (1999) (151)
- Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. (2001) (149)
- Monocyte subpopulations and cardiovascular risk in chronic kidney disease (2012) (149)
- Arterial stiffness: pathophysiology and clinical impact. (2004) (145)
- Hemodynamic study of 85 patients with borderline hypertension. (1973) (139)
- Stiffness of carotid artery wall material and blood pressure in humans: application to antihypertensive therapy and stroke prevention. (2000) (139)
- Arterial and venous compliance in sustained essential hypertension. (1987) (138)
- Aortic distensibility in normotensive, untreated and treated hypertensive patients. (1995) (136)
- Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease. (2000) (135)
- Use of phosphate-binding agents is associated with a lower risk of mortality. (2013) (135)
- Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. (2012) (134)
- The double challenge of resistant hypertension and chronic kidney disease (2015) (134)
- Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients. (1987) (133)
- Forearm reactive hyperemia and mortality in end-stage renal disease. (2004) (133)
- Prognostic application of arterial stiffness: task forces. (2002) (133)
- Increased stiffness of radial artery wall material in end-stage renal disease. (1997) (131)
- Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. (2015) (131)
- Interaction Between Hypertension and Arterial Stiffness: An Expert Reappraisal (2018) (129)
- Recent advances on large arteries in hypertension. (1998) (127)
- SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (2019) (125)
- Salt and water retention and calcium blockade in uremia. (1990) (121)
- Lipid management in patients with chronic kidney disease (2018) (119)
- Pathophysiology of cardiovascular disease in hemodialysis patients. (2000) (118)
- Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment. (1987) (116)
- The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study. (2016) (114)
- Pulmonary hypertension in CKD. (2013) (113)
- Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial (2014) (112)
- Assessment and significance of arterial stiffness in patients with chronic kidney disease (2008) (110)
- Pathophysiology of cardiovascular damage in the early renal population. (2001) (110)
- Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease. (1999) (110)
- Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. (2010) (108)
- Influence of age and end-stage renal disease on the stiffness of carotid wall material in hypertension. (1999) (100)
- Endothelin and cardiovascular remodelling in end-stage renal disease. (1998) (99)
- Hyperphosphataemia--a silent killer of patients with renal failure? (1999) (97)
- Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. (2003) (97)
- Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers. (2004) (94)
- Venous and arterial behavior during normal pregnancy. (1998) (93)
- A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application. (2014) (91)
- Prognostic significance of arterial stiffness measurements in end-stage renal disease patients (2002) (86)
- Arterial stiffness and function in end-stage renal disease. (2004) (85)
- Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry. (2014) (84)
- Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients (2017) (84)
- Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders (2006) (83)
- Different Aortic Reflection Wave Responses Following Long‐Term Angiotensin‐Converting Enzyme Inhibition And Beta‐Blocker In Essential Hypertension (2001) (82)
- COSMOS: the dialysis scenario of CKD-MBD in Europe. (2013) (80)
- Body height as a determinant of carotid pulse contour in humans (1992) (80)
- Arterial Stiffness in the Heart Disease of CKD. (2019) (78)
- Total Effective Compliance, Cardiac Output and Fluid Volumes in Essential Hypertension (1978) (77)
- The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. (2015) (75)
- Renal and systemic hemodynamics in sustained essential hypertension. (1984) (73)
- Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets? (2013) (73)
- Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. (1999) (72)
- Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition (1996) (72)
- Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles (2016) (71)
- Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS) (2014) (69)
- Isoproterenol Sensitivity and Total Body Clearance of Propranolol in Hypertensive Patients (1976) (68)
- Clinical management of the uraemic syndrome in chronic kidney disease. (2016) (67)
- Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. (2008) (67)
- Hypertension and the arterial system: clinical and therapeutic aspects. (1990) (65)
- Hemodynamic effects of head-down tilt in normal subjects and sustained hypertensive patients. (1983) (65)
- The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial. (2013) (65)
- Repeat hemodynamic determinations in borderline hypertension. (1978) (64)
- Intima–Media Thickness Is Linearly and Continuously Associated With Systolic Blood Pressure in a Population‐Based Cohort (STANISLAS Cohort Study) (2016) (63)
- Cardiopulmonary blood volume in borderline hypertension. (1974) (63)
- Carotid arterial haemodynamics after mild degrees of lower-body negative pressure in man. (1992) (63)
- Local shear stress and brachial artery functions in end-stage renal disease. (2007) (61)
- Arterial structure and function in end-stage renal disease (2008) (60)
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE (2015) (59)
- Large artery structure and function in hypertension and end‐stage renal disease (1998) (58)
- Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario? (2014) (57)
- Increased bone aluminum deposition after subtotal parathyroidectomy in dialyzed patients. (1985) (57)
- The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial. (2019) (57)
- Cardiovascular function in hemodialysis patients. (1991) (56)
- The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda (2011) (56)
- Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring Methods, Thresholds, and Patterns (2016) (55)
- Bone-vascular cross-talk. (2012) (55)
- Alterations of Arterial Function in End-Stage Renal Disease (2000) (55)
- Influence of body mass index on the association of weight changes with mortality in hemodialysis patients. (2013) (55)
- Aortic Aging in ESRD: Structural, Hemodynamic, and Mortality Implications. (2016) (55)
- Rapid Dextran Infusion in Essential Hypertension (1979) (54)
- Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. (2012) (53)
- Con: vascular calcification is a surrogate marker, but not the cause of ongoing vascular disease, and it is not a treatment target in chronic kidney disease. (2015) (53)
- Activation of platelets, coagulation and fibrinolysis in patients on long-term haemodialysis: influence of cuprophan and polyacrylonitrile membranes. (1990) (51)
- Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project. (2016) (51)
- Left ventricular hypertrophy: why does it happen? (2003) (50)
- Mechanisms of arterial calcifications and consequences for cardiovascular function (2013) (50)
- Blood pressure in the 'low-pressure system' and cardiac performance in essential hypertension. (1985) (50)
- Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease (2011) (50)
- Flow-mediated vasodilation in end-stage renal disease. (2011) (50)
- Carotid arterial hemodynamics in response to LBNP in normal subjects: methodological aspects. (1995) (49)
- Structural and functional modifications of peripheral large arteries in hypertensive patients. (1987) (49)
- Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients? (2015) (48)
- Cardiovascular risk in end-stage renal disease: vascular aspects. (2000) (48)
- Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link? (2011) (47)
- Intravascular volume, extracellular fluid volume, and total body water in obese and nonobese hypertensive patients. (1983) (47)
- Vascular reactivity to norepinephrine and hemodynamic parameters in borderline hypertension. (1975) (46)
- Arterial Stiffness in Chronic Kidney Disease and End-Stage Renal Disease (2018) (46)
- Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis (2012) (46)
- Mineral and bone disease pattern in elderly haemodialysis patients. (2010) (46)
- Role of arterial wall properties in the pathogenesis of systolic hypertension. (2005) (46)
- Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints (2019) (43)
- Hemodynamic Overload in End‐Stage Renal Disease Patients (1999) (42)
- Impairment of arterial function in chronic renal disease: prognostic impact and therapeutic approach. (2002) (40)
- Pulse pressure in sustained essential hypertension: a haemodynamic study. (1987) (39)
- Glomerular hypertension in renovascular hypertensive patients. (1991) (39)
- Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study. (2006) (39)
- Pathophysiology of left ventricular hypertrophy in dialysis patients. (1994) (39)
- Comparative Effects of Captopril and Isosorbide Dinitrate on the Arterial Wall of Hypertensive Human Brachial Arteries (1986) (38)
- Common Carotid Artery Diameter and Risk of Cardiovascular Events and Mortality: Pooled Analyses of Four Cohort Studies (2018) (37)
- Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination. (2001) (37)
- Multiphasic effects of blood pressure on survival in hemodialysis patients. (2016) (37)
- Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients. (2016) (36)
- Sodium, large arteries and diuretic compounds in hypertension (1992) (35)
- Influence of arterial pulse and reflective waves on systolic blood pressure and cardiac function. (1999) (35)
- Effect of converting enzyme inhibitors on hypertensive large arteries in humans. (1986) (35)
- Haemodynamics in patients with phaeochromocytoma. (1980) (35)
- The concept of ventricular/vascular coupling: functional and structural alterations of the heart and arterial vessels go in parallel. (1998) (35)
- Arterial compliance in uraemia. (1989) (34)
- Baroreflex sensitivity and cardiopulmonary blood volume in normotensive and hypertensive patients. (1977) (33)
- Ankle-brachial index and bone turnover in patients on dialysis. (2015) (33)
- Arterial mechanics predict cardiovascular risk in hypertension. (1997) (33)
- Essential Hypertension: An Approach to Clinical Data by the Use of Models (1979) (33)
- Bone-vascular axis in chronic kidney disease: a reality? (2009) (33)
- An indirect approach for the study of the elastic modulus of the brachial artery in patients with essential hypertension. (1986) (32)
- Effect of hemodialysis on cardiovascular rhythms in end-stage renal failure. (1995) (32)
- Increased arterial stiffness in end-stage renal failure: why is it of interest to the clinical nephrologist? (1994) (32)
- Left Ventricular Dysfunction in End-Stage Renal Disease: Echocardiographic Insights (1992) (31)
- Arterial calcification: cardiovascular function and clinical outcome. (2011) (31)
- Venous and arterial behavior during normal pregnancy. (1998) (31)
- Systemic compliance, renal hemodynamics, and sodium excretion in hypertension. (1984) (31)
- Control of cardiac output in essential hypertension. (1976) (30)
- Current management of secondary hyperparathyroidism: a multicenter observational study (COSMOS). (2008) (29)
- Arterial compliance in hypertension. (1989) (29)
- Systolic Hypertension in Patients with Arteriosclerosis Obliterans of the Lower Limbs (1987) (29)
- Influence of gender on the level of pulse pressure: the role of large conduit arteries. (1997) (29)
- Arterial sti ff ening and vascular calcifications in end-stage renal disease (2000) (29)
- Large artery function and alterations in hypertension (1995) (28)
- Controversy on optimal blood pressure on haemodialysis: lower is not always better. (2001) (28)
- Arterial stiffness and wave reflections following acute calcium blockade in essential hypertension. (1994) (28)
- Volume-dependent parameters in essential hypertension. (1977) (27)
- Association between aluminum accumulation and cardiac hypertrophy in hemodialyzed patients. (1989) (27)
- Cardiovascular and renal medicine, an expanding territory (2011) (27)
- Effect of head-down tilt on cardiovascular control in healthy subjects: a spectral analytic approach. (1995) (27)
- Tilt test in essential hypertension. Differential responses in heart rate and vascular resistance. (1987) (27)
- Hemodynamics of the carotid artery after vasodilation in essential hypertension. (1988) (27)
- Renal filtration fraction, effective vascular compliance, and partition of fluid volumes in sustained essential hypertension. (1981) (27)
- Cardiovascular disease in renal failure. (2004) (27)
- Relationships between cardiac output, heart rate and blood volume in essential hypertension. (1978) (26)
- Vascular Calcifications, Arterial Aging and Arterial Remodeling in ESRD (2013) (26)
- Arterial alterations in hypertension with a disproportionate increase in systolic over diastolic blood pressure (1996) (26)
- Modeling the implications of changes in vascular calcification in patients on hemodialysis. (2005) (26)
- Total effective compliance of the vascular bed in essential hypertension. (1978) (26)
- Altered blood volume regulation in sustained essential hypertension: a hemodynamic study. (1975) (26)
- Systemic Arterial Compliance in Patients with Arteriosclerosis Obliteransof the Lower Limbs: Observations on the Effect of Intravenous Propranolol (1982) (26)
- Contributive factors to cardiovascular hypertrophy in renal failure. (1989) (24)
- High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60 (2016) (24)
- Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA. (2018) (23)
- Forearm haemodynamics in obese normotensive and hypertensive subjects. (1988) (23)
- Soft Bone – Hard Arteries: A Link (2011) (23)
- Validity of Vascular Calcification as a Screening Tool and as a Surrogate End Point in Clinical Research. (2015) (22)
- The complexity of the cardio–renal link: taxonomy, syndromes, and diseases (2011) (21)
- Pulse Wave Velocity and Prognosis in End-Stage Kidney Disease (2018) (21)
- Increased response of brachial artery diameter to norepinephrine in hypertensive patients. (1988) (21)
- Meaning of the cardiac output-blood volume relationship in essential hypertension. (1982) (21)
- Renal hemodynamics in patients with sustained essential hypertension and in patients with unilateral stenosis of the renal artery. (1989) (21)
- Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis. (2016) (20)
- Arterial Compliance and Blood Pressure (2012) (20)
- Brachial artery diameter changes associated with cardiopulmonary baroreflex activation in humans. (1990) (19)
- Calcium‐Entry Blockers and Arterial Compliance in Hypertension (1989) (18)
- Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial (2016) (18)
- Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA. (2018) (18)
- Serum phosphate optimal timing and range associated with patients survival in haemodialysis: the COSMOS study. (2019) (18)
- The pressure-volume relationship in normotensive and permanent essential hypertensive patients. (1976) (17)
- Proximal and distal pulse pressure after acute antihypertensive vasodilating drugs in Wistar‐Kyoto and spontaneously hypertensive rats (1995) (17)
- Brachial Artery Cross‐Sectional Area and Distensibility Before and After Arteriolar Vasodilatation in Men with Sustained Essential Hypertension (1987) (17)
- Central haemodynamics and plasma prostaglandin E2 in borderline and sustained essential hypertensive patients before and after indomethacin. (1981) (17)
- Pressure-overload cardiomyopathy in end-stage renal disease (1999) (17)
- Blood pressure control in chronic hemodialysis patients (1996) (17)
- Thromboxane B2 in borderline and essential hypertensive patients. (1983) (17)
- Anti-hypertensive adrenergic-blocking agents: effects on sodium balance, the renin-angiotensin system and haemodynamics. (1975) (17)
- Elevation of brachial arterial blood velocity and volumic flow mediated by peripheral beta-adrenoreceptors in patients with borderline hypertension. (1985) (16)
- Atherosclerosis versus arterial stiffness in advanced renal failure. (2007) (16)
- [Mineral and bone status in French maintenance hemodialysis patients: a comparison of June 2005 and June 2008]. (2010) (16)
- Ultrafiltration intensification for achievement of dry weight and hypertension control is not always the therapeutic gold standard. (2011) (16)
- Heterogeneity of left ventricular hypertrophy--does it have clinical implications? (1998) (16)
- The ratio between ankle and brachial systolic pressure in patients with sustained uncomplicated essential hypertension. (1988) (16)
- The meaning of dopamine beta-hydroxylase in essential hypertension. (1975) (16)
- Vascular Disease and Atherosclerosis in Uremia (2000) (15)
- Large arteries haemodynamics: conduit versus cushioning function. (1997) (15)
- The future of European Nephrology ‘Guidelines’—a declaration of intent by European Renal Best Practice (ERBP) (2009) (15)
- Effect of cadralazine on brachial artery hemodynamics and forearm venous tone in essential hypertension (1986) (15)
- Determination of total effective vascular compliance in patients with sepsis syndrome. (1998) (15)
- Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension. (1977) (14)
- The use of echocardiography in observational clinical trials: the EURECA-m registry. (2013) (14)
- Effects of antihypertensive agents on carotid pulse contour in humans. (1992) (14)
- Is progression of coronary artery calcification influenced by modality of renal replacement therapy? A systematic review (2017) (14)
- Arterial Stiffness Gradient, Systemic Reflection Coefficient, and Pulsatile Pressure Wave Transmission in Essential Hypertension. (2019) (13)
- Cardiomyopathy in End‐Stage Renal Failure (1989) (13)
- The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trial (2016) (13)
- Hypertension and chronic kidney disease: respective contribution of mean and pulse pressure and arterial stiffness. (2015) (13)
- Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage. (2021) (13)
- Hysteresis of the venous pressure-volume relationship in the forearm of borderline hypertensive subjects. (1992) (13)
- Deferoxamine test and bone disease in dialysis patients with mild aluminum accumulation. (1989) (13)
- Venous system in essential hypertension. (1985) (12)
- INCREASED VASODILATOR RESPONSE DURING STIMULATION OF CARDIOPULMONARY BARORECEPTORS IN BORDERLINE HYPERTENSIVES (1989) (12)
- Relative prognostic impact of nutrition, anaemia, bone metabolism and cardiovascular comorbidities in elderly haemodialysis patients. (2018) (12)
- Split intrarenal hemodynamics in renovascular hypertension. (1991) (12)
- Efficacy of indapamide 1.5 mg, sustained release, in the lowering of systolic blood pressure (2004) (12)
- Major pathways of the reno–cardiovascular link: the sympathetic and renin–angiotensin systems (2011) (11)
- Cardiovascular disease in end-stage renal failure (2000) (11)
- Optimizing hypertension management in renal transplantation: a call to action. (2017) (11)
- Overhydratation and renin in hypertensive patients with terminal renal failure: a hemodynamic study. (1975) (11)
- Hypertension in kidney transplantation: a consensus statement of the ‘hypertension and the kidney’ working group of the European Society of Hypertension (2021) (11)
- Twenty-four hours of bed rest with head-down tilt: venous and arteriolar changes of limbs. (1991) (11)
- Clinical Outcomes in Secondary Hyperparathyroidism and the Potential Role of Calcimimetics (2008) (11)
- Clinical imaging of vascular disease in chronic kidney disease (2016) (11)
- Wave reflections. Clinical and therapeutic aspects (1993) (10)
- Weak within-individual association of blood pressure and pulse wave velocity in hemodialysis is related to adverse outcomes. (2019) (10)
- K026: Impact of aortic stiffness on survival in end-stage renal failure (1998) (10)
- Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure. (2017) (10)
- Optimizing hypertension management in renal transplantation: a call to action. (2017) (10)
- A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study (2013) (10)
- Estimating central blood pressure in the extreme vascular phenotype of advanced kidney disease. (2016) (10)
- Cardiopulmonary blood volume and plasma renin activity in normal and hypertensive humans. (1985) (10)
- Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease (2018) (9)
- Arterial function in renal failure. (1998) (9)
- Arteriosclerosis and Antihypertensive Response to Calcium Antagonists in End‐Stage Renal Failure (1991) (9)
- Abstract 4871: Circulating Endothelial Microparticles: A Novel Biomarker for Prediction of Subsequent Death and Cardiovascular Events in End-stage Renal Disease (2009) (9)
- Influence of sex and body weight on forearm hemodynamics in patients with sustained essential hypertension. (1991) (9)
- Effect of alpha‐methyldopa on cardiac output in hypertension (1979) (9)
- Intrinsic modifications of the brachial and radial arteries in hypertensive humans. (1994) (9)
- Comparison of forearm plethysmographic methods with brachial artery pulsed Doppler flowmetry in man. (1988) (9)
- Arterial remodeling and cardiovascular function in end-stage renal disease. (1997) (9)
- Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study (2017) (9)
- Plasma prostaglandins PGE2 and PGF2 alpha, total effective vascular compliance and renal plasma flow in essential hypertension. (1982) (8)
- Changes in arterial distensibility produced by converting enzyme inhibitors in hypertensive humans. (1987) (8)
- Cinacalcet, FGF23 and Cardiovascular Disease in Hemodialysis: The EVOLVE Trial (2015) (8)
- Total, peripheral and intrathoracic effective compliances of the vascular bed in normotensive and hypertensive patients. (1982) (8)
- Cardiovascular disease in end-stage renal failure: role of calcium-phosphate disturbances and hyperparathyroidism. (2002) (8)
- Prognostic values of left ventricular mass index in chronic kidney disease patients. (2019) (8)
- Central Artery Pulse Pressure in End-Stage Renal Disease: The Roles of Aortic Diameter, Aortic Stiffness and Wave Reflection (2011) (8)
- Arterial structure in hypertension and the effects of angiotensin converting enzyme inhibition. (1992) (8)
- Protocol of the SPARTE Study: A Strategy for Preventing Cardiovascular and Renal Events based on ARTErial Stiffness (2020) (8)
- Free erythrocyte protoporphyrin level and nerve conduction velocity in end-stage renal disease. (1975) (7)
- The common carotid circulation in patients with essential hypertension. (1988) (7)
- Age- and Sex-Related Changes in the Ratio Between Ankle and Brachial Systolic Pressure in Normal Subjects (1988) (7)
- Physical properties of the aorta and cardiac hypertrophy in essential hypertension. (1990) (7)
- [Incidence of arterial hypertension in French population after 60 years]. (2012) (7)
- Achievement of Kidney Disease: Improving Global Outcomes mineral and bone targets between 2010 and 2014 in incident dialysis patients in France: the Photo-Graphe3 study (2017) (7)
- [Arteriosclerosis and arterial calcifications in chronic kidney insufficiency]. (2005) (7)
- Excess volume removal following lung ultrasound evaluation decreases central blood pressure and pulse wave velocity in hemodialysis patients: a LUST sub-study (2020) (7)
- Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients (2018) (6)
- Difference in response of vascular resistance to orthostasis in patients with borderline and sustained essential hypertension. (1988) (6)
- [Cardiac anomalies in chronic renal failure]. (2000) (6)
- Arterial structure in hypertension and the effects of angiotensin converting enzyme inhibition (1992) (6)
- The lingering dilemma of arterial pressure in CKD: what do we know, where do we go? (2011) (6)
- ANTIHYPERTENSIVE EFFICACY OF INDAPAMIDE SR VS CANDESARTAN AND AMLODIPINE IN HYPERTENSIVE PATIENTS: THE X-CELLENT MAIN STUDY (2004) (6)
- Autonomic nervous system and large conduit arteries (1993) (6)
- Enhanced brachial artery compliance following perindopril in essential hypertension. (1988) (6)
- Cardiac output, oxygen consumption and renal blood flow in essential hypertension. (1984) (6)
- [Arterial hypertension, chronic renal insufficiency and dialysis]. (2007) (5)
- Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis (2021) (5)
- Arterial Pulse Wave and Calcium‐Channel Blockers in Hypertension (1994) (5)
- Arterial Calcinosis, Chronic Renal Failure and Calcium Antagonism (2012) (5)
- Cardiopulmonary baroreflex control of brachial artery diameter in sustained essential hypertension. (1989) (5)
- Aortic pulse wave velocity as a marker of atherosclerosis in hypertension (2001) (5)
- From Profusion to Confusion: The Saga of Managing Hypertension in Chronic Kidney Disease! (2015) (5)
- Parathyroid hormone and cardiovascular effects of dihydropyridines in chronic renal failure. (1990) (5)
- Renal and systemic hemodynamics in borderline hypertension. (1988) (5)
- A case-control study indicates that coagulation imbalance is associated with arteriosclerosis and markers of endothelial dysfunction in kidney failure. (2020) (5)
- [Pressure-independent improvement of aortic distensibility in hypertensive hemodialysed patients]. (1994) (4)
- Antihypertensive therapy and wave reflections. (1996) (4)
- Kidney disease 1 Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure (2014) (4)
- Central hemodynamics and cardiac output control in essential hypertensive patients. (1977) (4)
- Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study. (2020) (4)
- Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients. (2018) (4)
- Vascular disease and atherosclerosis in uremia. (2005) (4)
- Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study) (2015) (4)
- Erratum to: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. (2019) (4)
- [Comparison of central pulse pressure estimated from pulse wave propagation velocity and carotid pulse pressure measured by applantation tonometry]. (2002) (4)
- Renal haemodynamics, sodium balance and the capacitance system in essential hypertension. (1988) (4)
- [Hypertension and pulse pressure]. (2000) (4)
- Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study (2019) (4)
- Is blood pressure measured correctly in dialysis centres? Physicians' and patients' views. (2019) (4)
- Cardiac Hypertrophy and Aortic Distensibility in Essential Hypertension (1987) (4)
- Indirect, Noninvasive Evaluation of Pressure Wave Transmission in Essential Hypertension (1989) (3)
- Further study on the carotid baroreflex system in the cardiovascular deconditioning induced by head-down tilt. (1998) (3)
- Association of height and risk of myocardial infarction in women. (1995) (3)
- Cardiac Hypertrophy and Arterial Compliance Following Drug Treatment in Hypertension (1991) (3)
- Non-invasive assessment of vascular calcification and arterial stiffness (2010) (3)
- 172 Sexual Activity in Hypertensive Men Treated With Valsartan or Carvedilol (2001) (3)
- Arterial stiffness in hypertensive subjects with or without end-stage renal disease. (1997) (3)
- Promoting scientific collaboration and education in cardiovascular–renal medicine (2009) (3)
- APPLANATION TONOMETRY: SYSTOLIC BLOOD PRESSURE AND PULSE PRESSURE (PP) UNDER TREATMENT WITH INDAPAMIDE SR VERSUS CANDESARTAN AND AMLODIPINE (2004) (3)
- [Combination of low-dose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study]. (2002) (3)
- [Arterial stiffness, wave reflections and myocardial protection: the REASON project]. (2003) (3)
- AORTIC PULSE WAVE VELOCITY INDEX AND MORTALITY IN END-STAGE RENAL DISEASE: P3.170 (2000) (3)
- Awareness of Vascular Calcification Alters Mineral Metabolism Management: VASCULAR CALCIFICATION IN DIALYSIS PATIENTS (2010) (3)
- Differences in the mechanisms of borderline and permanent hypertension. (1977) (3)
- Renal replacement therapy for heart failure patients: in whom, when and which therapy to use? (2009) (3)
- [A new approach of the hemodynamics of human essential hypertension. Study of the control of cardiac output]. (1976) (3)
- Venous compliance in essential hypertension (1987) (3)
- Renal blood flow in man with essential hypertension. (1986) (3)
- [Hyperreactivity of the humeral artery to noradrenaline in essential hypertension patients]. (1987) (2)
- Effects of twenty-four hours of bed rest with head-down tilt on cardiopulmonary baroreflex control: preliminary study. (1989) (2)
- [Evaluation of the individual absolute cardiovascular risk. A mathematical equation and/or arterial measurement?]. (1999) (2)
- K025 Aortic pulse wave velocity (PWV): Marker of cardiovascular risk in hypertensive patients (1998) (2)
- INDAPAMIDE SR ANTIHYPERTENSIVE EFFICACY VS CANDESARTAN AND AMLODIPINE IN ISOLATED SYSTOLIC HYPERTENSIVE PATIENTS: THE X-CELLENT ISH SUBSET (2004) (2)
- Sex dependence of body fat distribution and fluid volumes in hypertension. (1988) (2)
- Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study (2020) (2)
- [Changes in mineral and bone disorder management in a French cohort of hemodialysis patients between 2008 and 2012: The National Bone and Mineral Metabolism observatory (Photo-Graphe 2 and 3)]. (2016) (2)
- Vascular Compliance in Hypertension: Therapeutic Implications (1987) (2)
- Benefits from angiotensin-converting enzyme inhibition in patients with renal failure: latest results (2003) (2)
- Author Correction: Lipid management in patients with chronic kidney disease (2018) (2)
- The spectrum of pressor-response to norepinephrine in normotensive and hypertensive patients. (1976) (2)
- Ambulatory blood pressure changes with lung ultrasound-guided dry-weight reduction in hypertensive hemodialysis patients: 12-month results of a randomized controlled trial (2021) (2)
- Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study. (2019) (2)
- The stroke volume in juvenile borderline hypertension. (1975) (2)
- Intrinsic alterations of the arterial wall in hypertension and effect of antihypertensive therapy (1987) (2)
- Total effective vascular compliance and renal filtration fraction in normotensive subjects and essential hypertensive patients. (1984) (2)
- [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe]. (2017) (2)
- [Venous tone of the limbs. Methods and comparison of 2 areas]. (1989) (2)
- Epidemiology and outcome - 1 (2009) (2)
- CIRCULATING ENDOTHELIAL MICROPARTICLES PREDICT CARDIOVASCULAR MORTALITY IN END-STAGE RENAL DISEASE: 3A.06 (2010) (1)
- What does STOP-2 tell us about management of hypertension? (2000) (1)
- Cardiopulmonary blood volume and plasma renin activity in man: preliminary report. (1985) (1)
- FP357 THE CLINICAL EVALUATION OF LOW DOSE HEPARIN IN HEMODIALYSIS: A PROSPECTIVE STUDY USING THE HEPARIN-COATED AN69 ST MEMBRANE (2007) (1)
- Arterial structure and function and blockade of the renin-angiotensin system in hypertension (2001) (1)
- [Measurement of the carotid intima-media thickness. An innovative technique for assessing cardiovascular risk]. (2001) (1)
- The possible impact of arterial compliance on cardiac hypertrophy in arterial hypertension. (1989) (1)
- APPLANATION TONOMETRY: ARTERY MECHANICAL PROPERTIES OF INDAPAMIDE SR VS CANOESARTAN AND AMLODIPINE (2004) (1)
- Borderline hypertension: correlation between the cardiac output and the vascular reactivity to norepinephrine. (1974) (1)
- β‐Blockade and Brachial Artery Hemodynamics in Hypertension (1990) (1)
- P-231: Slow release nifedipine (GITS) and lack of catecholamine reactivity in essential hypertension (2001) (1)
- Large arteries and calcium in hypertension (1993) (1)
- Disturbed Calcium-Phosphorus Metabolism/Arterial Calcifications: Consequences on Cardiovascular Function and Clinical Outcome (2010) (1)
- THE EFFECT OF DRY-WEIGHT REDUCTION GUIDED BY LUNG ULTRASOUND ON AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENTS (2019) (1)
- P-408: Antihypertensive efficacy of indapamide SR vs candesartan and amlodipine in isolated systolic hypertensive patients (2004) (1)
- 26 Pressure‐independent improvement in aortic distensibility in hypertensives undergoing haemodialysis (1994) (1)
- Reversion ofCardiac Hypertrophy andReduced Arterial Compliance After Converting EnzymeInhibition inEssential Hypertension (1988) (1)
- Erratum: Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: A study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA (Nephrology Dialysis Transplantation (2018) (gfy147) DOI: 10.1093/NDT/gfy147) (2018) (1)
- SuO002OPTIMAL BLOOD PRESSURE AND SURVIVAL IN HAEMODIALYSED PATIENTS. A PROSPECTIVE NATIONWIDE COHORT (2015) (0)
- POOR ADHERENCE TO BLOOD PRESSURE MEASUREMENT RECOMMENDATIONS IN EUROPEAN DIALYSIS CENTERS (2018) (0)
- Advanced Oxidation Protein Products , and Carotid Artery Intima-Media Thickness in End-Stage Renal Disease (2002) (0)
- Diameter, Velocity and Blood Flow of the Common Carotid Artery Before and After Vasodilation in Essential Hypertension (1986) (0)
- The meaning of dopamine p-hydroxylase in essential hypertension (2012) (0)
- [Cardiovascular repercussions of chronic hemodialysis]. (1990) (0)
- Lessons learned from EVOLVE for the planning of future global randomized trials in chronic kidney disease (2016) (0)
- Low-pressure system in essential hypertension. (1986) (0)
- EFFICACY OF NATRILIX SR IN THE LOWERING OF SYSTOLIC BLOOD PRESSURE: S6 (2004) (0)
- FO041THE EFFECT OF DRY-WEIGHT REDUCTION GUIDED BY LUNG ULTRASOUND ON AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENTS: A LUST SUB-STUDY (2019) (0)
- Opponent's comments. (2015) (0)
- Sodium, large arteries, and diuretic compounds in hypertension. (1994) (0)
- Survival with low- and high-flux dialysis (2020) (0)
- Influence of the autonomic nervous system on brachial artery diameter and compliance in normotensive and hypertensive patients. (1989) (0)
- Systemic hemodynamics in sustained essential and reno-vascular hypertension (1989) (0)
- E16: Plasma homocysteine (HCY), endothelin (ET) and left ventricular hypertrophy in patients with end-stage renal disease (ESRD) (1997) (0)
- Arterial Interactions with Mineral and Bone Disorders (2015) (0)
- Clinical consequences of arterial calcifications and soft-tissue calcifications in chronic kidney disease (2010) (0)
- P2640The effect of dry-weight reduction guided by lung ultrasound on ambulatory aortic blood pressure and arterial stiffness parameters in hemodialysis patients (2019) (0)
- Large arteries and calcium in hypertension. Pathophysiological and therapeutic aspects (1993) (0)
- [PP.07.30] AMBULATORY PULSE WAVE VELOCITY AND AUGMENTATION INDEX PREDICT CARDIOVASCULAR EVENTS AND ALL-CAUSE MORTALITY BETTER THAN OFFICE AND AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENT (2017) (0)
- Renal anaemia - CKD 5D (2012) (0)
- Heart and bone in CKD - A (2013) (0)
- Evolving concepts of pathogenesis of cardiovascular disease in chronic uremia: Role of hyperparathyroidism, calcium-phosphate metabolism, and their therapy (2002) (0)
- Cardiovascular complications in end-stage renal disease patients (2015) (0)
- The reason project: blood pressure evaluation (2001) (0)
- DIALYSIS. EXTRACORPOREAL DIALYSIS: TECHNIQUES AND ADEQUACY FP473 THE USE OF HIGH-FLUXMEMBRANES IS NOTASSOCIATED WITH IMPROVED SURVIVALOF PATIENTS ON HEMODIALYSIS (2015) (0)
- Venous system, extracellular fluid volume and the kidney in essential hypertension (1987) (0)
- Acute volume expansion and pumping function of the heart in sustained essential hypertension (1989) (0)
- The Age–Stiffness Relationships of Elastic and Muscular Arteries in a Control Population and in End-Stage Renal Disease Patients (2023) (0)
- FP685THE PROGNOSTIC SIGNIFICANCE OF THE BLOOD PRESSURE-PULSE WAVE VELOCITY ASSOCIATION FOR CARDIOVASCULAR OUTCOMES AND MORTALITY IN HEMODIALYSIS PATIENTS (2019) (0)
- P1394ASSOCIATION BETWEEN PARATHYROID HORMONE AND MORTALITY IN HAEMODIALYSIS: THE DIABETES MAKES THE DIFFERENCE (2020) (0)
- Evaluation de la compliance artérielle chez l'insufficient rénal (1991) (0)
- THE EFFECT OF DRY-WEIGHT REDUCTION GUIDED BY LUNG ULTRASOUND ON AMBULATORY AORTIC BLOOD PRESSURE AND ARTERIAL STIFFNESS PARAMETERS IN HEMODIALYSIS PATIENTS (2019) (0)
- [Index of arterial and venous compliance and echocardiographic parameters in essential permanent arterial hypertension]. (1987) (0)
- 15th International Conference on Dialysis Advances in Chronic Kidney Disease 2013 (2013) (0)
- A955 Differential Influence of Pregnancy on Limbs Venous Tone in Humans (1990) (0)
- PowerPoint Slides for: High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60 (2016) (0)
- [Regional hemodynamics of the forearm. Comparison between obese and non-obese hypertensive patients]. (1988) (0)
- [Current physiopathological concerns in arterial hypertension]. (1990) (0)
- [Abnormalities of intrarenal hemodynamics in essential and renovascular hypertension in man]. (1989) (0)
- Under embargo until June 2 , 2014 , 09 : 30 local time ! LATE BREAKING CLINICAL TRIALS Hyperparathyroidism : Medical or Surgical Treatment ? (2014) (0)
- Supplementary Material for: High Pulse-Wave Velocity Defines a Very High Cardiovascular Risk Cohort of Dialysis Patients under Age 60 (2016) (0)
- Arteriosclerosis and antihypertensive response to calcium antagonists in end-stage renal failure. (1991) (0)
- [Influence of the autonomic nervous system on the diameter and compliance of the brachial artery in normotensive subjects and hypertensive patients]. (1989) (0)
- Non‐invasive ultrasonic study of maximal aortic blood acceleration in patients with borderline and sustained essential hypertension (1988) (0)
- Blockade in Uremia (2005) (0)
- [Comparison of renal hemodynamics in 2 types of arterial hypertension, essential and renovascular, in man. Physiopathological implications]. (1988) (0)
- [Plasma prostaglandins and the renin-aldosterone system in patients with labile or permanent essential hypertension]. (1978) (0)
- FP473THE USE OF HIGH-FLUX MEMBRANES IS NOT ASSOCIATED WITH IMPROVED SURVIVAL OF PATIENTS ON HEMODIALYSIS (2015) (0)
- Autonomic Nervous System and Brachial Artery Diameter in Normotensive and Hypertensive Patients (1990) (0)
- Calf venous modifications during pregnancy: preliminary report. (1991) (0)
- [Labile arterial hypertension and prostaglandins]. (1977) (0)
- Beta-blockade and brachial artery hemodynamics in hypertension. (1990) (0)
- dialysate calcium is an independent risk factor for Low parathyroid hormone status induced by high cardiovascular death in hemodialysis patients (2016) (0)
- FC 079HIGH SERUM PHOSPHATE, A NOVEL POTENTIAL RISK FACTOR FOR BONE FRAGILITY FRACTURES IN THE COSMOS STUDY (2021) (0)
- E32 Stiffness of radial artery wall material in essential hypertension and end-stage renal disease (1997) (0)
- Cardiovascular complications in CKD 5D (2) (2011) (0)
- Bone disease - 2 (2009) (0)
- Large Artery Remodeling and Chronic Kidney Disease (2014) (0)
- 383 ARTERIAL HEMODYNAMICS IN CALCIFIED ARTERIOPATHIES AND THEIR INFLUENCE ON MICROCIRCULATION (2012) (0)
- Prostaglandins and plasma renin activity in hypertensive patients. (1980) (0)
- Increased bone aluminum deposition after parathyroidectomy in hemodialyzed patients (1985) (0)
- Subject Index, Vol. 6 (Suppl. 2), 1986 (1986) (0)
- FP592TWO-YEAR EVOLUTION OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS BACK TO DIALYSIS AFTER KIDNEY TRANSPLANT FAILURE. (2018) (0)
- VASODILATATION INDEPENDENT FROM ENDOTHELIUM IS ALTERED IN RELATION WITH ARTERIAL STIFFNESS: P 467 (2004) (0)
- SP543AMBULATORY ARTERIAL STIFNESS PARAMETERS PREDICT CARDIOVASCULAR AND ALL-CAUSE MORTALITY BETTER THAN OFFICE AND AMBULATORY BLOOD PRESSURE IN HEMODIALYSIS PATIENTS (2017) (0)
- NDT Perspectives A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Blood Pressure in Non-dialysis-dependent Chronic Kidney Disease: an endorsement with some caveats for real-life applica (2014) (0)
- SaO048THE EFFECT OF DRY-WEIGHT REDUCTION GUIDED BY LUNG ULTRASOUND ON AMBULATORY AORTIC BLOOD PRESSURE AND ARTERIAL STIFFNESS PARAMETERS IN HEMODIALYSIS PATIENTS: A LUST SUB-STUDY (2019) (0)
- SP608LEFT VENTRICULAR MASS IS A POWERFUL PROGNOSTIC FACTORFOR ALL-CAUSE MORTALITY IN END STAGE KIDNEY DISEASE PATIENTS: A COMBINED ANALYSIS OF TWO EUROPEAN COHORTS (2016) (0)
- [Non-invasive study of the role of carotid distension in the baroreflex response to the arteriolar vasodilator cadralazine in essential hypertension]. (1986) (0)
- P279 NUTRITIONAL AND METABOLIC PATTERN IN 9000 MAINTENANCE HEMODIALYSIS PATIENTS FROM THE FRENCH NATIONAL CALCIUM AND PHOSPHATE OBSERVATORY: ANALYSIS FROM JUNE 2008 DATA (2009) (0)
- FP626LOW PARATHYROID HORMONE STATUS INDUCED BY HIGH DIALYSATE CALCIUM IS AN INDEPENDENT RISK FACTOR OF CARDIOVASCULAR DEATH IN HAEMODIALYSIS PATIENTS (2015) (0)
- SP333MANAGEMENT OF BONE AND MINERAL METABOLISM DISORDERS BEFORE THE DIALYSIS STAGE REMAINS STILL PERFECTIBLE DATA FROM THE FRENCH PHOSPHORUS AND CALCIUM SURVEY « PHOTO-GRAPHE» (2017) (0)
- FP402RELATIVE RISK OF MORTALITY IN HEMODIALYSIS PATIENTS PRESCRIBED CALCIUM-FREE AND CALCIUM-CONTAINING PHOSPHATE BINDING AGENTS (2015) (0)
- Central Pulse Pressure in end-stage renal disease: the role of aortic diameter, aortic stiffness and wave reflection (2008) (0)
- FP633PULSE WAVE VELOCITY AND PROGNOSIS IN CHRONIC KIDNEY FAILURE (2018) (0)
- MO102LUNG ULTRASOUND-GUIDED DRY-WEIGHT REDUCTION DECREASES AMBULATORY BLOOD PRESSURE LEVELS IN HYPERTENSIVE HEMODIALYSIS PATIENTS: LONG-TERM ANALYSIS OF A LUST SUB-STUDY* (2021) (0)
- MP344THE INTERDIALYTIC PERIOD FOR BLOOD COLLECTION INFLUENCES SERUM PHOSPHORUS AND THE RISK OF MORTALITY IN THE COSMOS STUDY (2016) (0)
- [Methods for studying vasodilator agents in arterial hypertension]. (1990) (0)
- HIGH BLOOD PRESSURE INCIDENCE AND PREDICTIVE FACTORS ACCORDING TO AGE IN THE IPC COHORT: PP.30.28 (2011) (0)
- SAT-019 ACEi/ARBs, β-blockers or Both in incident End-Stage Renal Disease patients without Cardiovascular Disease: A Propensity-Matched longitudinal study in a Nationwide cohort (2019) (0)
- Effects of Parathyroidectomy on Plasma Different Parathyroid Hormone Fragments Levels in Chronic Kidney Disease Patients (2017) (0)
- Anaemia in CKD 5D (2011) (0)
- [Evaluation of arterial compliance in renal insufficiency]. (1991) (0)
- [Cardiac hypertrophy and arterial compliance after antihypertensive treatment]. (1991) (0)
- Selected Abstracts from the 31th International Vicenza Course on Critical Care Nephrology. Vicenza, June 11-14, 2013 (2013) (0)
- Erratum. (2020) (0)
- Baroreflex sensitivity andcardiopulmonary blood volume innormotensive andhypertensive patients (1977) (0)
- [New approach to the hemodynamics of human essential hypertension. Study of mean values]. (1976) (0)
- Vascular reactivity to angiotensin in borderline hypertension. (1974) (0)
- [Hemodynamic effect of propranolol in permanent essential arterial hypertension]. (1974) (0)
- SP55824-MONTH SAFETY OUTCOMES OF BIOSIMILAR EPOETIN ALFA IN THE EUROPEAN MONITOR-CKD5 PHARMACOEPIDEMIOLOGICAL STUDY OF ANAEMIA IN HAEMODIALYSIS (2016) (0)
- P1584The prognostic significance of the blood pressure-pulse wave velocity association for cardiovascular outcomes and mortality in hemodialysis patients (2019) (0)
- PP.30.28 HIGH BLOOD PRESSURE INCIDENCE AND PREDICTIVE FACTORS ACCORDING TO AGE IN THE IPC COHORT (2012) (0)
- Systemic hemodynamics in patients with pheochromocytoma (1989) (0)
- [Value of arterial rigidity measurements in cardiovascular pathology]. (1999) (0)
- [Increased vasodilation response to the stimulation of low pressure mechanoreceptors in borderline hypertension]. (1989) (0)
- In order to improve CKD – MBD outcomes , in 2003 , the National Kidney Foundation launched the Kidney Dialysis (2012) (0)
- HEMODYNAMIC DETERMINANTS OF CORONARY AND STROKE MORTALITY IN HEMODIALYSED PATIENTS: 2B.6 (2004) (0)
- THE PROGNOSTIC SIGNIFICANCE OF THE BLOOD PRESSURE-PULSE WAVE VELOCITY ASSOCIATION FOR CARDIOVASCULAR OUTCOMES AND MORTALITY IN HEMODIALYSIS PATIENTS (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gérard Michel London?
Gérard Michel London is affiliated with the following schools: